Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGLTS:0QQM 68 EV-to-FCF is 8.70 as of Aug. 28, 2026, which is 49% below its 10-year median of 17.04. GuruFocus rates LTS:0QQM with a GF Score™ of 68/100 and a GF Value™ of CHF148.06 (Modestly Undervalued). Among 409 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 84.6% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, IVF hartmann Holding AG's Enterprise Value is CHF201.6 Mil.
IVF hartmann Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was CHF23.2 Mil. Therefore, IVF hartmann Holding AG's EV-to-FCF for today is 8.70.
The historical rank and industry rank for IVF hartmann Holding AG's EV-to-FCF or its related term are showing as below:
LTS:0QQM'
s EV-to-FCF Range Over the Past 10 Years
Min: -30.28 Med: 17.04 Max: 109.5
Current: 8.7
During the past 13 years, the highest EV-to-FCF of IVF hartmann Holding AG was 109.50. The lowest was -30.28. And the median was 17.04.
LTS:0QQM's EV-to-FCF is ranked better than 84.6% of 409
companies
in the Medical Devices & Instruments industry
Industry Median: 24.74
vs LTS:0QQM: 8.70
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IVF hartmann Holding AG (LTS:0QQM) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IVF hartmann Holding AG's PE Ratio (TTM) for today is calculated as:
IVF hartmann Holding AG's share price for today is CHF129.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IVF hartmann Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was CHF8.470.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's EV-to-FCF falls into.
IVF hartmann Holding AG's current Enterprise Value is CHF201.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IVF hartmann Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was CHF23.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG (LTS:0QQM) has a EV-to-FCF of 8.70 as of Aug. 28, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on IVF hartmann Holding AG and its competitors. This is 49% below median its historical median of 17.04. According to the industry distribution chart, IVF hartmann Holding AG ranks #63 out of 409 companies in the Medical Devices & Instruments industry, placing it in the top 15.4%.
Is IVF hartmann Holding AG's EV-to-FCF too high?
IVF hartmann Holding AG's current EV-to-FCF of 8.70 is 49% below median its 10-year median of 17.04. The Medical Devices & Instruments industry median EV-to-FCF is 24.74. IVF hartmann Holding AG's value of 8.70 is 64.8% below this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #63 out of 409 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, IVF hartmann Holding AG has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #63 out of 409 companies for EV-to-FCF. This places IVF hartmann Holding AG in the top 15% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 24.74. IVF hartmann Holding AG's value of 8.70 is 64.8% below this benchmark. While the company's 10-year median is 17.04 vs. the industry median of 24.74, IVF hartmann Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.74, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current EV-to-FCF of 8.70 is 64.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current EV-to-FCF is 8.70, which is 49% below median its own 10-year median of 17.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (LTS:0QQM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF148.06, compared to a current price of CHF129.50 — trading 12.5% below its estimated fair value. The current EV-to-FCF is 8.70, which is 49% below median its 10-year median of 17.04 and 64.8% below the Medical Devices & Instruments industry median of 24.74. IVF hartmann Holding AG's overall GF Score™ is 68/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For IVF hartmann Holding AG (LTS:0QQM), the current EV-to-FCF is 8.70 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (LTS:0QQM) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF129.50 is trading 12.5% below its estimated GF Value™ of CHF148.06.
GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.
Key valuation signals for LTS:0QQM:
EV-to-FCF: 8.70 (49% below median its 10-year median of 17.04)
GF Value™: CHF148.06 vs. price of CHF129.50 (12.5% below fair value)
Industry Position: 64.8% below the Medical Devices & Instruments median (#63 of 409)
No single metric tells the full story. See the LTS:0QQM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
68GF Score
Get the complete analysis for LTS:0QQM
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QQM has been successfully added to your 
